Hyaluronic Acid: Ingredient Traceability and Supply Chain Transparency

---

Abstract

Hyaluronic acid (HA), also known as hyaluronan, is a glycosaminoglycan widely distributed in the connective tissues of living organisms. Since its entry into the health food and cosmetics markets in the late twentieth century, the sourcing pathways, manufacturing processes, and supply chain transparency of HA raw materials have become central topics of concern for regulators, academics, and consumers alike. This paper takes an ingredient-traceability perspective to systematically review the raw material forms of hyaluronic acid, the principal production processes, the supply chain structure of the market, and the actionable criteria consumers can use to assess the credibility of product information. No medical efficacy claims are made herein.

---

I. Chemical Nature and Raw Material Forms of Hyaluronic Acid

Hyaluronic acid is a linear polysaccharide chain composed of alternating units of D-glucuronic acid and N-acetyl-D-glucosamine. Its chemical structure is highly conserved between animal sources and microbial fermentation products, and this structural identity is the scientific basis upon which raw materials from different origins can be used interchangeably in industrial production.

In the commercial raw material market, hyaluronic acid is typically classified into three primary molecular weight ranges:

• High molecular weight HA: generally ≥1,000 kDa; predominantly used in cosmetic ingredients;
• Medium molecular weight HA: 200–999 kDa; the most widely used across industrial applications;
• Low molecular weight HA / oligomeric hyaluronic acid: <50 kDa; listed as a distinct category by some food ingredient suppliers.

Molecular weight directly affects the physical properties of the raw material (e.g., viscosity, water solubility); however, molecular weight in itself is not equivalent to any physiological efficacy. When reading product labels, consumers should treat molecular weight as a raw material specification parameter rather than an efficacy indicator.

---

II. Sourcing Pathways: Animal Extraction vs. Microbial Fermentation

2.1 Animal Tissue Extraction (Traditional Pathway)

Hyaluronic acid was first isolated and identified in 1934 by the American scientist Karl Meyer from bovine vitreous humor. For several decades thereafter, industrial production relied primarily on extraction from rooster combs (cock's comb)—one of the richest natural sources of hyaluronic acid in the animal kingdom, with a dry-weight content of approximately 7,500 mg/100 g.

The supply chain nodes for the animal extraction pathway are: poultry farms → slaughter and processing facilities → raw material extraction plants → refining and purification → finished raw material. Within this chain, animal quarantine records, certificates of origin, and batch traceability files represent the three critical document dimensions for assessing raw material compliance.

The principal supply chain risks associated with animal-derived raw materials include:

• 1. Supply disruptions caused by animal disease outbreaks (e.g., avian influenza);
• 2. Inconsistent molecular weight distribution between batches;
• 3. Risk of residual protein exceeding permitted limits, with stricter labeling disclosure obligations for consumers with protein allergies;
• 4. Greater difficulty in obtaining religious dietary certifications (Halal / Kosher).

2.2 Microbial Fermentation (Mainstream Pathway)

From the 1990s onward, microbial fermentation processes using Streptococcus zooepidemicus as the host strain progressively displaced animal extraction to become the dominant pathway for industrial HA production worldwide. From the 2000s onward, some manufacturers further transitioned to engineered strains of non-animal-derived organisms such as Bacillus subtilis, in order to completely eliminate the risk of carrying animal pathogens and to meet vegan certification requirements.

The supply chain nodes for the fermentation pathway are more consolidated: carbon/nitrogen source raw material supply (primarily agricultural products such as glucose and corn steep liquor) → master cell bank management → bioreactor cultivation → extraction and purification (including precipitation, ultrafiltration, ion exchange, and other steps) → drying → finished raw material.

Compared with animal extraction, the fermentation pathway offers greater traceability in the following respects:

• Strain origins are documentable, with strain identification reports available;
• Intra-batch molecular weight distribution is more uniform;
• Residual protein levels are generally lower, and the purification process is more readily standardized;
• The agricultural origin of carbon source materials can be independently traced.

---

III. Fermentation Process Flow and Critical Quality Control Points

For a compliant batch of fermentation-derived hyaluronic acid raw material, the quality control documentation chain typically covers the following stages:

(1) Origin and purity of carbon and nitrogen source materials

The country of origin of primary carbon sources such as glucose, pesticide residue testing reports, and non-GMO declarations (where applicable) serve as the starting point of raw material-level traceability documentation.

(2) Strain batch records

Documentation of the strain's source institution, identification number, number of passages, and results of pathogenicity testing. For *Streptococcus zooepidemicus* strains, proof of testing demonstrating the absence of residual streptococcal toxins (e.g., streptolysin) is required.

(3) Fermentation process parameter records

Including key process parameters such as temperature, pH, dissolved oxygen, and culture duration, as well as records of intermediate sampling and testing.

(4) Certificate of Analysis (CoA) for the purified raw material

A conforming release CoA should include at a minimum: hyaluronic acid content (%), molecular weight (viscosity-average or weight-average), moisture, ash, heavy metals (lead, arsenic, mercury, cadmium), microbial limits (total aerobic plate count, mold, and yeast), and residual protein content.

(5) Supplier audits and GMP certification

GMP (Good Manufacturing Practice) certification at the raw material supplier level is the core basis upon which downstream finished-product manufacturers conduct supplier management. finished-product manufacturers sourcing hyaluronic acid raw materials typically require suppliers to provide third-party certification documents or to undergo periodic on-site audits.

---

IV. Landscape of Japan's Hyaluronic Acid Raw Material Industry Chain

Japan is one of the world's significant producers and consumers of hyaluronic acid raw materials. From an industry structure perspective, there is a clear division of labor between raw material manufacturing and finished-product manufacturing.

On the raw material supply side, Japan is home to several long-established hyaluronic acid raw material producers, some of whose accumulated expertise in fermentation processes and strain technology dates back to the 1980s. These raw material manufacturers typically supply downstream finished-product manufacturers in the cosmetics, food, and health food sectors; raw material specifications and quality documentation are formulated in accordance with relevant guidelines issued by the Food Safety Commission of Japan and the Ministry of Health, Labour and Welfare.

On the finished-product manufacturing side, the GMP management system for health foods is primarily implemented through the GMP Conformity Certification Program of the Japan Health and Nutrition Food Association (JHNFA). This certification sets out explicit requirements for incoming raw material inspection, storage management, production process control, and finished-product release. Certified facilities are subject to periodic document reviews and on-site inspections. Facilities holding JHNFA GMP Conformity Certification have their entire production workflow subject to the documentary constraints of that certification system, making it an important reference indicator for assessing the regulatory compliance of health food production within Japan.

From an import perspective, mainland China is also the world's largest exporter of hyaluronic acid raw materials, with several large-scale fermentation production enterprises. importers typically require Chinese raw material suppliers to provide test data conforming to Japan's Food Sanitation Act and the Standards for Food Additives, and the materials are subject to random sampling inspections by the Ministry of Health, Labour and Welfare at the port of entry.

---

V. Standards for Supply Chain Transparency and Traceability

5.1 Core Elements of "Ingredient Transparency"

In the context of health foods, "raw material ingredient transparency" is not merely the act of printing a country name on the packaging; rather, it constitutes a comprehensive information disclosure system that typically encompasses:

• Declaration of raw material country of origin: clearly identifying the country in which the hyaluronic acid raw material was manufactured (not merely the country of packaging or finished-product manufacture);
• Declaration of production process pathway: distinguishing between animal-derived and fermentation-derived origins, and stating the animal-derived status of the fermentation strain;
• Accessibility of third-party test reports: whether consumers or downstream purchasers are able to obtain batch CoAs upon request;
• Verifiability of certification marks: certification marks appearing on products—such as GMP, organic, or non-GMO—can be verified by consumers through the certifying body's official website or certification number.

5.2 Information Asymmetry and Label Interpretation

Japan's current Act for Improvement of Nutrition and Eating Habits and Act against Unjustifiable Premiums and Misleading Representations specify mandatory items for health food labels, but the "country of origin of raw materials" is not a mandatory disclosure item for all product categories. This means the market contains products that merely state "Manufactured in Japan " without disclosing the origin of the raw materials—"Manufactured in Japan" indicates that final processing was completed within Japan, and does not equate to "the raw materials used originate from Japan."

When reading labels on hyaluronic acid products, consumers should pay particular attention to the following information:

---

VI. Transparency Issues in Molecular Weight Labeling

Molecular weight is one of the most important specification parameters for hyaluronic acid raw materials and is also the area in which transparency of industry label information varies most significantly.

High molecular weight and low molecular weight / oligomeric hyaluronic acid differ fundamentally in their physicochemical properties, yet some product labels merely indicate "hyaluronic acid" in general terms without specifying the molecular weight range, leaving consumers unable to determine how the purchased product corresponds to the raw material specifications used in the published literature.

Responsible ingredient transparency should include:

• Stating the molecular weight range of the hyaluronic acid used (in kDa units) on the label or product page;
• Where hyaluronic acid of multiple molecular weight grades is present, listing the content of each separately;
• Specifying the molecular weight testing method employed (e.g., gel permeation chromatography (GPC) or viscometry).

---

VII. Actionable Guidance for Consumers

The following are practical information-verification steps that consumers can actually carry out when purchasing and evaluating hyaluronic acid health food products:

Step 1: Confirm completeness of daily intake labeling

The product label should clearly state the serving size, the number of servings per day, and the daily hyaluronic acid content in mg. Products that omit the daily content figure have a fundamental deficiency in information transparency.

Step 2: Verify the validity of GMP certification

If a product states JHNFA GMP Conformity Certification, consumers may visit the JHNFA official website and enter the certification number (typically in a five-digit format) on the "List of GMP-Certified Facilities (GMP)" page to confirm that the certification status is active and covers the relevant hyaluronic acid product category.

Step 3: Inquire about the raw material sourcing pathway

Contact the manufacturer's customer service channel to ask: whether the hyaluronic acid raw material is of animal-extracted or fermentation-derived origin; if fermentation-derived, whether the strain used is of animal origin; and which country the raw material was produced in. Responsible manufacturers are generally able to respond to these questions in writing within a reasonable timeframe.

Step 4: Request third-party test reports

Consumers may request the manufacturer to provide the CoA for the relevant raw material batch. Key items to check include whether the heavy metal testing covers all four elements—lead, arsenic, mercury, and cadmium—and whether the testing institution is a laboratory accredited to ISO/IEC 17025.

Step 5: Distinguish marketing language from verifiable facts

When product promotional materials refer to language such as "hydration," "moisturizing," or "joint lubrication," consumers should be aware of the restrictions law places on the scope of permitted claims for health foods. Foods with health claims —comprising Foods for Specified Health Uses, Nutrient Function Foods, and Foods with Function Claims —must follow strict approval or notification procedures when making function claims; ordinary foods may not, in any form, imply medical or physiological effects. Consumers should exercise caution when encountering promotional statements that exceed this scope.

---

Conclusion

The traceability and transparency of hyaluronic acid raw materials are a microcosm of the health food industry's commitment to informational integrity. From the technological transition from animal extraction to microbial fermentation, to the establishment of batch test reports and GMP certification systems, every node in the supply chain carries documentable, verifiable information. Consumers have both the right and the capacity to verify this information through public channels, rather than relying solely on self-declarations printed on product packaging.

In an era of increasingly accessible information, manufacturers that proactively disclose raw material origin, process pathway, test data, and certification numbers to consumers demonstrate a level of transparency that itself serves as an effective signal of product credibility. Conversely, products that avoid disclosing the above information warrant a correspondingly higher degree of scrutiny.

Ingredient traceability is not a marketing label—it is an objective reflection of the quality of supply chain management.

---

*This article has been compiled on the basis of publicly available materials from the health food industry and relevant regulations. All statements are limited to verifiable factual dimensions pertaining to raw material ingredients, manufacturing processes, labeling, and certification. Nothing herein constitutes medical advice, nor does it constitute an evaluation of the efficacy of any specific product. This product is a dietary supplement, not a pharmaceutical, and no therapeutic claims are made.*